Counterforce Health (Page 22)

More issues

How to Get Darzalex Covered by Cigna in New York: Appeal Templates, Timelines & Prior Authorization Guide

Answer Box: Getting Darzalex Covered by Cigna in New York If Cigna denies Darzalex (daratumumab) coverage, you can appeal within 180 days. Most denials stem from insufficient prior therapy documentation or missing age verification (≥18 required). Quick action steps: 1) Call Cigna at 1-800-882-4462 for clarification, 2) Gather complete treatment

How to Get Orladeyo (Berotralstat) Covered by Humana in Washington: Timeline, Appeals & Forms

Answer Box: Getting Orladeyo Covered by Humana in Washington Orladeyo (berotralstat) is typically covered by Humana as a specialty tier drug requiring prior authorization for hereditary angioedema (HAE) prophylaxis. The fastest path to approval involves: 1) Confirming HAE diagnosis with lab results (C1-INH levels/function), 2) Submitting complete prior authorization

How to Get Soliris (Eculizumab) Covered by UnitedHealthcare in New Jersey: Complete Guide to Prior Authorization, Appeals, and State Protections

Quick Answer: Getting Soliris Covered in New Jersey Eligibility: UnitedHealthcare requires prior authorization for Soliris (eculizumab) with strict documentation of approved conditions (PNH, aHUS, gMG, NMOSD), meningococcal vaccination records, and REMS compliance. Fastest path: Submit PA through UnitedHealthcare provider portal with complete vaccination records and specialist prescription. First step today:

How Long Does It Take to Get Keytruda (Pembrolizumab) Approved by UnitedHealthcare in New York? Complete Timeline Guide

Answer Box: Getting Keytruda Approved by UnitedHealthcare in New York Timeline: 3-5 business days for standard review, 72 hours for expedited cases. Fastest path: Submit complete prior authorization through UnitedHealthcare Provider Portal with NCCN-aligned documentation and required biomarker testing. Start today: Contact your oncologist to gather pathology reports, biomarker results

Renewing Zanzalintinib (XL092) Coverage with Humana in Washington: Timeline, Documentation & Appeal Steps

Answer Box: Renewing Zanzalintinib (XL092) Coverage with Humana in Washington Zanzalintinib (XL092) is an investigational drug requiring compassionate use program enrollment through Exelixis, as it's not FDA-approved. Humana typically covers investigational drugs only within clinical trials or approved compassionate use programs. To renew coverage: (1) Confirm continued eligibility

How to Get Strensiq (asfotase alfa) Covered by Cigna in Illinois: Decision Tree, Appeals, and Next Steps

Answer Box: Your Path to Strensiq Coverage in Illinois Cigna requires strict prior authorization for Strensiq (asfotase alfa) for pediatric-onset hypophosphatasia (HPP). You qualify if you have documented perinatal, infantile, or juvenile-onset HPP with low alkaline phosphatase and genetic confirmation. Next steps: (1) Gather diagnostic proof including ALPL mutation testing,

Garadacimab (Andembry) Coverage by Humana in Texas: Formulary Alternatives, Appeals, and Prior Authorization Guide

Quick Answer: Getting Garadacimab (Andembry) Covered by Humana in Texas Garadacimab is not on Humana's 2025 Medicare formulary, requiring a formulary exception request. Texas residents have strong appeal rights through internal reviews (65 days to file) and external reviews via Independent Review Organizations. First step: Have your prescriber

How to Get Duopa Covered by Blue Cross Blue Shield in Pennsylvania: Appeals Guide with Forms and Timelines

Answer Box: Getting Duopa Covered by Blue Cross Blue Shield in Pennsylvania Duopa requires prior authorization from all Pennsylvania Blue Cross Blue Shield plans in 2024. Success requires documenting advanced Parkinson's disease with motor fluctuations, failed oral therapy trials, and surgical candidacy for PEG-J placement. If denied, Pennsylvania&

How to Get Qalsody (Tofersen) Covered by Aetna CVS Health in Ohio: Forms, Appeals, and State Protections

Answer Box: Getting Qalsody (Tofersen) Covered by Aetna CVS Health in Ohio Aetna CVS Health requires prior authorization for Qalsody (tofersen) in Ohio. The fastest path to approval: 1) Confirm SOD1 mutation with genetic testing, 2) Submit complete PA request via Availity portal or fax 1-855-734-9389 with clinical documentation, 3)

How to Get Dojolvi (Triheptanoin) Covered by UnitedHealthcare in Michigan: Complete PA Guide with Appeal Scripts

Answer Box: Getting Dojolvi Covered by UnitedHealthcare in Michigan Dojolvi (triheptanoin) requires prior authorization from UnitedHealthcare for long-chain fatty acid oxidation disorders (LC-FAOD). Key requirements: molecular genetic confirmation of LC-FAOD, prescription from a board-certified medical geneticist, no concurrent MCT products, and dosing ≤35% of daily calories. First step: Download the